NDA 205947 describes DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM, which is a drug marketed by
Lupin and
Watson Labs Inc and is included in three NDAs. It is available from
one supplier. Additional details are available on the
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM profile page.
The generic ingredient in DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM is
drospirenone; ethinyl estradiol; levomefolate calcium. There is one
drug master file entry for this compound. Three
suppliers are listed for this compound. Additional details are available on the
drospirenone; ethinyl estradiol; levomefolate calcium profile page.